Celgene Corporation (CELG)

CELG (NASDAQ:Drugs)
$124.91
pos +1.43
+1.16%
Today's Range: 120.35 - 125.05 | CELG Avg Daily Volume: 3,269,400
Last Update: 05/17/13 - 4:00 PM EDT
Volume: 4,122,228
YTD Performance: 57.36%
Open: $124.56
Previous Close: $123.48
52 Week Range: $58.53 - $131.82
Oustanding Shares: 417,122,477
Market Cap: 51,506,283,460
6-Month Chart
TheStreet Ratings Grade for CELG
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 20 21 21 21
Moderate Buy 1 2 2 2
Hold 4 3 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.36 1.29 1.35 1.35
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 02/27/06
Price Earnings Ratio: 37.53
Price Earnings Comparisons:
CELG Sector Avg. S&P 500
37.53 37.50 17.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
25.02% 76.63% 107.81%
GROWTH 12 Mo 3 Yr CAGR
Revenue 13.70 1.05 0.27
Net Income 10.50 0.87 0.23
EPS 15.80 1.00 0.26
Earnings for CELG:
EBITDA 2.20B
Revenue 5.51B
Average Earnings Estimates
Qtr (06/13) Qtr (09/13) FY (12/13) FY (12/14)
Average Estimate $1.31 $1.29 $5.21 $1,984.89
Number of Analysts 4 4 4 5
High Estimate $1.36 $1.37 $5.46 $9,899.00
Low Estimate $1.25 $1.26 $5.08 $5.91
Prior Year $1.12 $1.19 $4.50 $5.21
Growth Rate (Year over Year) 16.74% 8.61% 15.78% 37,997.70%
Update Chart
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
BeautyBubble
BeautyBubble: Chart Sugar. member hands me over yet another great site. $CELG 's option chain. http://t.co/pcrQPieBU1 reminds me to watch my OptionMentor
3 hours ago from web
BeautyBubble
BeautyBubble: Chart Sugar. member just handed me a new site I have never visited. $CELG is highlighted name. http://t.co/bpjiYY4dFv full bodied info.
3 hours ago from web
thebscott
thebscott: @RetroWallSt $P is intriguing as is $CELG
7 hours ago from Twitter for BlackBerry
liamkmac
liamkmac: RT @Fibonacciqueen: $CELG setup: http://t.co/vmwmjjQupm
12 hours ago from web
Fibonacciqueen
Fibonacciqueen: $CELG setup: http://t.co/vmwmjjQupm
12 hours ago from web
tlmontana
tlmontana: So many of you have been along for the ride for my BTD in $GOOG $LNKD $AMZN $KORS $CELG $BBRY $CSTR $SODA $WFM - now I'm cautious cc $SPY
14 hours ago from Twitter for iPhone
Weeklyoptions
Weeklyoptions: At WOP we have few $EBAY $CMG $AMZN $LNKD $HPQ $NFLX $SPWR $CTSH $GOOG $FAZ $BAC $AAPL $SPY $UVXY $CELG $GMCR $IBM http://t.co/4P8gl2vkWX
14 hours ago from Investors Hub Post Tweeter
Weeklyoptions
Weeklyoptions: At WOP we have few $EBAY $CMG $AMZN $LNKD $HPQ $NFLX $SPWR $CTSH $GOOG $FAZ $BAC $AAPL $SPY $UVXY $CELG $GMCR $IBM http://t.co/psVqwQSbFo
14 hours ago from Investors Hub Post Tweeter
ronin245
ronin245: $CELG tradeable L again off 122 but ran far, they took some off to join other parties like $GS $IBM even the refiners $MRO $VLO bidding up
16 hours ago from StockTwits Web
DDNotesMaker
DDNotesMaker: Another DD sheet for $CELG was generated, check out http://t.co/taMLmDiD5s
17 hours ago from DDNotesMakerPost

Biotech Makes a Comeback

By

Jim Cramer

 | May 10, 2013 | 12:52 PM EDT

Just a natural change in leadership.

Big Pharma Has Lost Its Way

By

Jim Cramer

 | May 3, 2013 | 7:23 AM EDT

Many of these firms are pouring money into share buybacks -- instead of their long-term pipelines.

Off the Charts

By

Scott Redler

 | Apr 24, 2013 | 6:50 PM EDT

Banks continued higher, basic materials outperformed.

National Lemming Day

By

Jim Cramer

 | Apr 24, 2013 | 1:16 PM EDT

It’s the only thing that explains today’s action.

Rules of the Game: Spread Out the Risk

By

Kate Stalter

 | Apr 22, 2013 | 11:00 AM EDT

Beware of cramming all your funds in one basket.

The Biotech Revaluation Is On

By

Jim Cramer

 | Apr 17, 2013 | 6:20 AM EDT

These four names in particular have made some stunning moves.

Remember, Everything Gets Exaggerated at First

By

Jim Cramer

 | Apr 15, 2013 | 7:43 AM EDT

Keep that in mind as the market reacts to China this morning.

Health Care Stocks Still Promising

By

Kate Stalter

 | Apr 11, 2013 | 10:24 AM EDT

Plenty of leadership remains in the health care sector and there’s reason to see further potential.

Consider Playing Catch-Up Via Biotech

By

Jim Cramer

 | Apr 10, 2013 | 3:32 PM EDT

Deep-in-the-money call options on these five names could provide a healthy return.

The Real Tech Boom Is Still Just Beginning

By

Roger Arnold

 | Apr 2, 2013 | 3:00 PM EDT

If you're overly cautious about biotech, you could incur some major opportunity costs.

Columnist Conversation / Market Updates

A Special Thank You to Barron's
By

Brian Sozzi

 | May 18, 2013 | 6:48 AM EDT
I greatly appreciate the team for sharing my remembrance to Alan Abelson. It really did come from the heart. I am becom...

How to Obliterate an Earnings Call
By

Brian Sozzi

 | May 18, 2013 | 6:33 AM EDT
I approach an earnings call as I do eating a lobster: tear it apart and leave nothing for the dogs in the back alley. ...
See more »

Our Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.